Narrative updates are currently in beta.

Loading...
Back to narrative

Update shared on24 Aug 2025

Fair value Increased 7.41%
AnalystConsensusTarget's Fair Value
US$58.00
24.9% undervalued intrinsic discount
24 Aug
US$43.57
Loading
1Y
-9.0%
7D
1.2%

Despite a slight reduction in revenue growth forecasts and stable profit margins, ScanSource’s consensus analyst price target has increased from $54.00 to $58.00.


What's in the News


  • Repurchased 681,035 shares for $25.07 million, completing a total buyback of 4,538,140 shares (18.67%) for $182.91 million under the 2021 buyback program.
  • No shares repurchased under the buyback announced in May 2025.
  • Issued earnings guidance for FY 2026, expecting net sales of $3.1 billion to $3.3 billion.
  • Added to the Russell 2000 Dynamic Index.

Valuation Changes


Summary of Valuation Changes for ScanSource

  • The Consensus Analyst Price Target has risen from $54.00 to $58.00.
  • The Consensus Revenue Growth forecasts for ScanSource has fallen from 4.7% per annum to 4.4% per annum.
  • The Net Profit Margin for ScanSource remained effectively unchanged, moving only marginally from 2.67% to 2.71%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.